NLM Digital Collections

Search

Start Over Subjects Drug Costs -- trends ✖Remove constraint Subjects: Drug Costs -- trends

2. Snapshots of recent state initiatives in Medicaid prescription drug cost control

Author(s):
Young, Katherine, author
Garfield, Rachel, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, February 2018
Subject(s):
Cost Control -- statistics & numerical data
Cost Control -- trends
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicaid -- trends
Disclosure
Drugs, Generic -- economics
Economics, Pharmaceutical
Federal Government
Forecasting
Formularies as Topic
State Government
Humans
United States
United States. Food and Drug Administration.

4. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices

Author(s):
Biniek, Jean Fugleston, author
Johnson, William, author
Publication:
Washington, DC : Health Care Cost Institute, January 2019
Subject(s):
Diabetes Mellitus, Type 1 -- drug therapy
Diabetes Mellitus, Type 1 -- economics
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Insulin -- economics
Insulin -- therapeutic use
Drug Costs -- trends
Forecasting
Insulins -- economics
Insulins -- therapeutic use
Humans
United States

7. Rx Watchdog report: comparative measures of price change for prescription drugs and other goods

Publication:
Washington, D.C. : AARP Public Policy Institute, c2009
Subject(s):
Drug Costs -- statistics & numerical data
Health Expenditures -- statistics & numerical data
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs -- trends
Drugs, Generic -- economics
Forecasting
Health Expenditures -- trends
Inflation, Economic
Humans
United States

10. Rx price watch report: trends in retail prices of specialty prescription drugs widely used by Medicare beneficiaries : 2005 to 2009

Publication:
Washington, D.C. : AARP Public Policy Institute, c2012
Subject(s):
Drug Costs -- trends
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs -- statistics & numerical data
Drugs, Generic -- economics
Forecasting
Pharmaceutical Preparations -- economics
Humans
United States

15. Rx Price Watch report: retail prices for widely used brand name drugs increase considerably prior to generic competition

Publication:
Washington, D.C. : AARP Public Policy Institute, c2011
Subject(s):
Drug Costs -- trends
Drug Therapy -- statistics & numerical data
Economic Competition
Pharmaceutical Preparations -- economics
Drug Approval
Drug Costs -- statistics & numerical data
Forecasting
Medicare Part D -- economics
Patents as Topic
Humans
United States

26. Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 2015

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2019
Subject(s):
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Insurance, Health, Reimbursement -- statistics & numerical data
Insurance, Health, Reimbursement -- trends
Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
Medicare Part D -- trends
Economics, Pharmaceutical -- statistics & numerical data
Economics, Pharmaceutical -- trends
Forecasting
Prescription Drugs -- economics
Humans
United States

27. Medicare spending trends 2010-2016: increase in prescription drug spending more than offsets lower beneficiary costs for other services

Author(s):
Schoen, Cathy, author
Willink, Amber, author
Davis, Karen, author
Publication:
[New York, N.Y.] : The Commonwealth Fund, November 2019
Subject(s):
Financing, Personal -- trends
Health Expenditures -- trends
Medicare -- economics
Medicare -- trends
Drug Costs -- trends
Forecasting
Medicare Part D -- economics
Medicare Part D -- trends
Poverty
Humans
United States

30. Changes in the list prices of prescription drugs, 2017-2023

Author(s):
Bosworth, Arielle, author
Sheingold, Steven, author
Finegold, Kenneth, author
Sayed, Bisma A., author
De Lew, Nancy, author
Sommers, Benjamin D., author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, October 6, 2023
Subject(s):
Drug Costs -- trends
Prescription Drugs -- economics
United States

31. Competition in prescription drug markets, 2017-2022

Author(s):
Parasrampuria, Sonal, author
Murphy, Stephen J. (Stephen James), author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services, December 2023
Subject(s):
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Economic Competition
Drug Industry -- economics
Drug Industry -- trends
Prescription Drugs -- economics
United States